FDA-cleared M. genitalium product
July 2018—SpeeDx’s ResistancePlus MG Positive Control kit has been cleared by the FDA.
Webinars and Sponsored Roundtables — Register Now
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
Blood collection tubes for cfDNA, CTCs
July 2018—Biocept has launched its CEE-Sure blood collection tubes for research use only, and internationally distributed through VWR. CEE-Sure BCTs allow for the intact transport of liquid biopsy samples at room temperature.
Echo Lumena gets FDA clearance
July 2018—Immucor announced its next-generation, fully automated Echo Lumena received FDA clearance. Echo Lumena is the company’s fifth-generation benchtop immunohematology instrument, designed for small- to mid-volume laboratories.
High-def PCR respiratory assay
July 2018—ChromaCode announced the publication of studies from Dartmouth-Hitchcock Medical Center and USC’s Keck School of Medicine highlighting the utility of the company’s HDPCR chemistry and the performance of the HDPCR respiratory assay, for research use only.
BD unveils informatics, automation solutions at ECCMID
July 2018—Becton Dickinson introduced several informatics and automation solutions for clinical laboratories at the European Congress of Clinical Microbiology and Infectious Diseases in Madrid, in April.
First Atellica Solution with Aptio installed in U.S.
July 2018—Siemens Healthineers completed the first U.S. installation of its Atellica Solution immunoassay and clinical chemistry analyzers connected to Aptio Automation at Access Medical Laboratories in Jupiter, Fla.
FDA oncology approvals
July 2018—FDA granted in June accelerated approval to pembrolizumab (Keytruda, Merck) for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma or for patients who have relapsed after two or more prior lines of therapy.
Expanded use of Validate Fibrinogen kit
July 2018—LGC Maine Standards announced that its Validate Fibrinogen for linearity and calibration verification is available on Instrumentation Laboratory’s ACL Top 500, Siemens Healthineers’ Sysmex CS-2500, and Diagnostica Stago’s STA-R Evolution hemostasis test systems.
Streck launches sed-rate analyzer
July 2018—Streck and Diesse Diagnostica Senese have introduced the Cube 30 Touch, an automated instrument for high-volume erythrocyte sedimentation rate testing in EDTA tubes.
Qiagen launches QIAstat-Dx in Europe
July 2018—Qiagen announced the European launch of its QIAstat-Dx, a next-generation multiplex molecular diagnostic that provides a one-step, fully integrated molecular analysis of common syndromes as tested for in syndromes in infections, oncology, and other diseases.